These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 2412887)

  • 1. [Clinical pharmacokinetics of pyromecaine. Prolonged intravenous infusion and the relation between its antiarrhythmic effect and its concentration].
    Piotrovskiĭ VK; Blagodatskikh SV; Metelitsa VI; Smirnov VK; Gorshkov VA
    Farmakol Toksikol; 1985; 48(4):83-6. PubMed ID: 2412887
    [No Abstract]   [Full Text] [Related]  

  • 2. [Comparison of the results of ethacizin pharmacodynamics and pharmacokinetics in a single intravenous administration].
    Shugushev KhKh; Gneushev ET; Smetnev AS; Kukes VG; Rozenshtraukh LV
    Kardiologiia; 1985 Apr; 25(4):32-5. PubMed ID: 2410654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effects of infusion rate of Changrolin on drug concentration in blood and ECG (author's transl)].
    Qu ZX; Cao CY; Zhuang YH
    Yao Xue Xue Bao; 1980 Aug; 15(8):449-55. PubMed ID: 7211388
    [No Abstract]   [Full Text] [Related]  

  • 4. [Blood levels, clinical effects and pharmacokinetics during treatment with oral ethmozine].
    Chen Y; Zhu JR; Li ZS
    Zhonghua Xin Xue Guan Bing Za Zhi; 1987 Feb; 15(1):34-6, 63. PubMed ID: 2440654
    [No Abstract]   [Full Text] [Related]  

  • 5. [Pharmacodynamics of allapinine during long-term infusion in patients with chronic ischemic heart disease and frequent ventricular extrasystole].
    Khakimov AG; Merkulova IN; Semeĭkin OV; Frolova EP; Mansurova GL; Mazaev AV; Ruda MIa
    Kardiologiia; 1991 Nov; 31(11):58-62. PubMed ID: 1725191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The pharmacokinetics and pharmacodynamics of the new Soviet anti-arrhythmia preparation allapinin].
    Abdalla A; Rulin VA; Mazur NA; Chikovani SI
    Farmakol Toksikol; 1988; 51(5):47-9. PubMed ID: 2463182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparative clinical study of the effectiveness of the new anti-arrhythmia agents, trimecaine and pyrromecaine].
    Pavlova TS; Riabokon' OS; Ivanova LA; Sumarokov AB
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1983; 6(2):67-72. PubMed ID: 6196040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical evaluation of the anti-arrhythmia effect of trimecaine].
    Merzon AK; Doviner AD; Degtiar AN; Rodin IN; Rudenko NN
    Vrach Delo; 1983 May; (5):23-6. PubMed ID: 6192593
    [No Abstract]   [Full Text] [Related]  

  • 9. [Safety of long-term therapy with a combination of various anti-arrhythmia agents].
    Abdalla A; Mazur NA; Sumarokov AB; Iavorskaia NV
    Klin Med (Mosk); 1989 Mar; 67(3):79-82. PubMed ID: 2473246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical trial of a new antiarrhythmic agent and study of its blood levels].
    Desruelles J; Cuingnet E; Gérard A; Ducatillon P; Waucampt JJ
    Arch Mal Coeur Vaiss; 1968 Jun; 61(6):869-78. PubMed ID: 4175924
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacokinetics of novel atrial-selective antiarrhythmic agent vernakalant hydrochloride injection (RSD1235): influence of CYP2D6 expression and other factors.
    Mao ZL; Wheeler JJ; Clohs L; Beatch GN; Keirns J
    J Clin Pharmacol; 2009 Jan; 49(1):17-29. PubMed ID: 18927241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effectiveness of intravenous infusion of ethmozin in patients with chronic ventricular arrhythmias].
    Merkulova IN; Piotrovskiĭ VK; Metelitsa VI; Romina IN; Blank ML
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1989; 12(1):25-31. PubMed ID: 2472818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical application of pharmacokinetics for antiarrhythmic drugs.
    Harrison DC
    Arch Mal Coeur Vaiss; 1981 Dec; 74 Spec No():65-72. PubMed ID: 6803703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Blood bunaphthine during dynamic physical exercise and anti-arrhythmic action].
    Rossi P; Cernigliaro C; Rognoni G; Carcano G
    G Ital Cardiol; 1976; 6(7):1233-7. PubMed ID: 64374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical pharmacokinetics and hemodynamics of ethacizin in the acute period of myocardial infarct].
    Beloborodov VL; Klimov AV; Tiukavkina NA; Kaverina NV; Pokazeeva ET
    Farmakol Toksikol; 1986; 49(5):32-6. PubMed ID: 3770172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pyromecaine--a new anti-arrhythmia preparation improving myocardial blood supply].
    Samvelian VM; L'vov MV; Prianishnikova NT; Varosian MA; Bagramian IG
    Kardiologiia; 1985 Apr; 25(4):85-9. PubMed ID: 2410657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [On the clinical use of a new drug in the therapy of coronary insufficiency].
    Bracchetti D; Spada E
    G Clin Med; 1966 Dec; 47(12):1261-82. PubMed ID: 4173047
    [No Abstract]   [Full Text] [Related]  

  • 18. [The effect of verapamil in coronary insufficiency and cardiac arrhythmia].
    Bobkova VI; Solomonova LN; Majorov JM; Karpickij VS; Mazurova SV
    Arzneimittelforschung; 1970 Sep; 20():Suppl 9a:1285+. PubMed ID: 4098327
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical trial of propafenone (rytmonorm) in arrhythmia of patients with ischemic heart disease)].
    Dobrotvorskaia TE; Koroleva ON; Gordina OV; Marakanova AV
    Klin Med (Mosk); 1996; 74(3):51-3. PubMed ID: 8926706
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical study of the effectiveness of mexitil in the treatment of patients with extrasystole in old and advanced age].
    Korkuschko OW; Butenko AG; Schatilo WB
    Z Gerontol; 1987; 20(3):149-53. PubMed ID: 2442897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.